Skip to main navigation Skip to search Skip to main content

Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease

  • L. van Dussen
  • , A. Zimran
  • , E. M. Akkerman
  • , J. M.F.G. Aerts
  • , M. Petakov
  • , D. Elstein
  • , H. Rosenbaum
  • , D. Aviezer
  • , E. Brill-Almon
  • , R. Chertkoff
  • , M. Maas
  • , C. E.M. Hollak
  • University of Amsterdam
  • Hebrew University of Jerusalem
  • Clinical Center of Serbia
  • Rambam Health Care Campus Israel
  • Protalix Carmiel

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases